PARP7 inhibitors

Ribon, backed by biopharma majors, raises $65M to take PARP7 inhibitor deeper into the clinic
Fierce Biotech
Wed, 07/14/21 - 10:35 am
Ribon Therapeutics
funding
PARP7 inhibitors